Faced with an epidemic that continues to worry in France because of the increase in contamination and overloaded hospitals, the French executive has put in more new restrictions and expects deliveries of vaccines from next week.
As the world continues its bitter fight against covid-19 despite dwindling vaccine deliveries in the face of barely hidden vaccine nationalism, France has managed to secure new shipments of vaccine to alleviate the health situation.
According to the Minister for Industry, Agnès Pannier-Runacher, Paris should receive at least 3 million doses of anticoronavirus vaccine as early as “next week”.
In a statement on Europe 1, the minister said that France will receive “important” deliveries of vaccines from several laboratories, which will allow the country to achieve one of its objectives.
“We expect large deliveries next week: nearly 3 million doses will arrive in France which are confirmed by the various laboratories,” she said.
“This allows us to confirm the objective of 30 million French people vaccinated at the end of June,” added the Minister.
France should receive between 2.5 million and 3 million doses according to her, with deliveries mainly by BioNTech-Pfizer with “nearly 2 million doses from the week of April 5”.
The government expects to reach even 4 million doses by the beginning of May. While deliveries of vaccines are late worldwide, particularly because of the demands of producing countries who want to vaccinate their populations first, ignoring laboratory orders, France can count on “Moderna (which) has always caught up with its deliveries ”.
Or between the new single-dose vaccine put on the market, from Johnson and Johnson which must deliver its orders shortly, according to the minister.
The European Commission had threatened Britain to block exports of AstraZeneca vaccines produced on European soil after the laboratory failed to honor its commitments on time.
Saturday, Agnès Pannier-Runacher confirmed the application of this measure by affirming that the EU has “secured the doses, with the blocking of doses in Italy”. These are 29 million doses of vaccines, 16 of which were intended for the European market.
“On the remaining doses, we are in discussion. The advantage is that we now have control over these doses, ”added Pannier-Runacher.